Cargando…
Regulation of PD-L1 Expression by NF-κB in Cancer
Immune checkpoints are inhibitory receptor/ligand pairs regulating immunity that are exploited as key targets of anti-cancer therapy. Although the PD-1/PD-L1 pair is one of the most studied immune checkpoints, several aspects of its biology remain to be clarified. It has been established that PD-1 i...
Autores principales: | Antonangeli, Fabrizio, Natalini, Ambra, Garassino, Marina Chiara, Sica, Antonio, Santoni, Angela, Di Rosa, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724774/ https://www.ncbi.nlm.nih.gov/pubmed/33324403 http://dx.doi.org/10.3389/fimmu.2020.584626 |
Ejemplares similares
-
The Emerging Interplay Between Recirculating and Tissue-Resident Memory T Cells in Cancer Immunity: Lessons Learned From PD-1/PD-L1 Blockade Therapy and Remaining Gaps
por: Gitto, Silvia, et al.
Publicado: (2021) -
OMIP‐079: Cell cycle of CD4
(+) and CD8
(+) naïve/memory T cell subsets, and of Treg cells from mouse spleen
por: Natalini, Ambra, et al.
Publicado: (2021) -
Antigen‐specific CD8 T cells in cell cycle circulate in the blood after vaccination
por: Simonetti, Sonia, et al.
Publicado: (2019) -
Dysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during Diseases
por: Bernardini, Giovanni, et al.
Publicado: (2016) -
Multiple Levels of Chemokine Receptor Regulation in the Control of Mouse Natural Killer Cell Development
por: Bernardini, Giovanni, et al.
Publicado: (2014)